J. Walt

J. Wilensky, J. Walt, T. Chiang, 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

A Markov modelled pharmacoeconomic analysis of bimatoprost 0.03% in the treatment of glaucoma as an alternative to filtration surgery in Italy*

S. Holmstrom, M. Vetrugno, J. Walt, 2005, Current medical research and opinion.

A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension.

J. Walt, Jeffrey T. Lee, 2004, Survey of ophthalmology.

EFFICACY AND SAFETY OF TWO OR MORE DEXAMETHASONE INTRAVITREAL IMPLANT INJECTIONS FOR TREATMENT OF MACULAR EDEMA RELATED TO RETINAL VEIN OCCLUSION (SHASTA STUDY)

D. Roth, R. Dreyer, A. Capone, 2014, Retina.

Patient Impact of Allergic Conjunctivitis as Measured by the Eye Allergy Patient Impact Questionnaire (EAPIQ)

D. Lorenz, P. Buchholz, J. Walt, 2003 .

PES19 INITIAL DEVELOPMENT AND VALIDATION OF THE EYE ALLERGY PATIENT IMPACT QUESTIONNAIRE (EAPIQ)

J. Walt, P. Buchholz, A. Wojcik, 2002 .

Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)

J. Jumper, J. Walt, K. Blinder, 2018, Clinical ophthalmology.

Development and Validation of the Eyelash Satisfaction Questionnaire

J. Cole, S. Burgess, J. Walt, 2016, Aesthetic surgery journal.

Prevalence of treated dry eye disease in a managed care population.

T. Mclaughlin, J. Walt, J. Smeeding, 2001, Clinical therapeutics.

Estimated Comparative Costs of Achieving a 20% Reduction in Intraocular Pressure with Bimatoprost or Latanoprost in Patients with Glaucoma or Ocular Hypertension

J. Walt, R. Fiscella, 2006, Drugs & aging.

Comparing Adherence and Persistence Across 6 Chronic Medication Classes

J. Benner, J. Yeaw, J. Walt, 2009, Journal of managed care pharmacy : JMCP.

Comments on The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries

S. Holmstrom, M. Aagren, P. Buchholz, 2006, Current medical research and opinion.

Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.

R. Noecker, J. Walt, 2006, American journal of ophthalmology.

Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study

D. Roth, R. Dreyer, J. Walt, 2015, BMC Ophthalmology.

Minimal clinically important difference for the ocular surface disease index.

P. Asbell, S. Pflugfelder, J. Walt, 2010, Archives of ophthalmology.

The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine.

L. Pasquale, M. Rudikoff, A. Robin, 1995, Archives of ophthalmology.

Brimonidine in the prevention of intraocular pressure elevation following argon laser trabeculoplasty.

G. Spaeth, R. Stamper, J. Walt, 1993, Archives of ophthalmology.

Cost of Illness of Glaucoma

J. Walt, R. Fiscella, Jeffrey T. Lee, 2012, PharmacoEconomics.

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)

J. Jumper, J. Walt, K. Blinder, 2017, Clinical ophthalmology.

Utility assessment among patients with dry eye disease.

J. Doyle, R. Schiffman, G. Jacobsen, 2003, Ophthalmology.

Quality of Life in Glaucoma and Three Other Chronic Diseases

P. Buchholz, S. Law, J. Walt, 2009, Drugs & aging.

The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries

S. Holmstrom, M. Aagren, P. Buchholz, 2006, Current medical research and opinion.

Current management of glaucoma and the need for complete therapy.

J. Walt, S. Mckinnon, T. Bramley, 2008, The American journal of managed care.

Rasch analysis in the development of a simplified version of the national eye institute visual-function questionnaire-25 for utility estimation

N. Bressler, R. Hays, D. Revicki, 2012, Quality of Life Research.

A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.

Philip P. Chen, R. P. Mills, Robert M Feldman, 2006, Archives of ophthalmology.

The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser trabeculoplasty.

A. Coleman, A. Robin, J. Morrison, 1993, Ophthalmology.

Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.

J. Carruthers, S. Cox, J. Walt, 2013, Aesthetic surgery journal.

Healthcare charges in patients with glaucoma who undergo laser trabeculoplasty

L. Pasquale, J. Walt, L. Stern, 2009, Advances in therapy.

Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe

N Orzalesi, J J Doyle, J. Doyle, 2005, British Journal of Ophthalmology.

Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma

S. Holmstrom, M. Aagren, P. Buchholz, 2005, Current medical research and opinion.

The impact of diabetic retinopathy on health-related quality of life.

Wei Liu, Sanjay Sharma, P. Buchholz, 2005, Current opinion in ophthalmology.

A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.

R. Gold, J. Nordmann, E. Chen, 2005, Acta ophthalmologica Scandinavica.

Glaucoma medication persistence with a fixed combination versus multiple bottles

E. Higginbotham, J. Walt, A. Guckian, 2009, Current medical research and opinion.

Late-stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries*

A. Bron, J. Thygesen, M. Aagren, 2008, Current medical research and opinion.

Assessing Quality of Life in Patients With Glaucoma Using the Glaucoma Quality of Life-15 (GQL-15) Questionnaire

Stuart Graham, Ivan Goldberg, S. Graham, 2009, Journal of glaucoma.

Evaluation of quality of life for patients with glaucoma.

G. Spaeth, J. Walt, J. Keener, 2006, American journal of ophthalmology.

Pharmacotherapy compliance in patients with ocular hypertension or primary open-angle glaucoma.

C. Traverso, J. Walt, L. Stern, 2009, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Development of a preference-based index from the National Eye Institute Visual Function Questionnaire-25.

N. Bressler, R. Hays, D. Revicki, 2014, JAMA ophthalmology.

Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study

D. Roth, R. Dreyer, A. Capone, 2015, BMC Ophthalmology.

Healthcare charges in patients who transition from ocular hypertension to primary open-angle glaucoma based on ophthalmic coding data

L. Pasquale, J. Walt, L. Stern, 2009, Advances in therapy.

The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration

P. Buchholz, S. Law, J. Walt, 2009, Clinical ophthalmology.

The relationship between pre‐operative hypertension and intra‐operative haemodynamic changes known to be associated with postoperative morbidity

J. Davids, M. Crowther, B. Biccard, 2018, Anaesthesia.

Topical cyclosporine versus emulsion vehicle for the treatment of brittle nails: a randomized controlled pilot study.

B. Chakraborty, S. Whitcup, J. Walt, 2014, Journal of Drugs in Dermatology.